Institutional investors purchased a net $4.7 million shares of MDCO during the quarter ended March 2015 and now own 112.30% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PHARUS MANAGEMENT SA Bought 7.0 Thousand shares of Medicines Co
STATE STREET GLOBAL ADVISORS LTD... Bought 37.00 shares of Medicines Co